SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " rope " 100 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
Grocery prices across Europe: Where is food most expensive and why?
Grocery prices vary widely across Europe. Bread can cost more than three times as much in one country as in another. Euronews Business takes a closer look at the differences and what drives them.
Politicians are afraid to fix taxes. So 100 citizens tried.
Connecticut’s property tax system has been broken for decades and the politicians have failed to fix the problem. So now, they’re trying something new: a citizens assembly. (Citizens assemblies are also old. They go back to Ancient Greece, when lawmakers were chosen not through elections, but through random lotteries.) Today on the show, Connecticut’s citizens assembly. It's like jury duty, but for taxes. About hundred random people from all around Connecticut come together to try to solve the state’s property tax problem. They wrestle with whether they should raise taxes, cut spending, find efficiencies, or a mix of everything. Will this alternative attempt to solve the unsolvable succeed, or will it be politics as usual?It’s a modern case study of what happens when politicians step aside to let citizens decide what’s best. Come along as we talk to the professor who helped put this assembly together, learn from the citizens involved how this experiment changed them, and meet the politician who agreed to take their proposals to the state legislature. Planet Money will be at Kilkenomics Festival 2026. Tickets here.Read: - Our book: Planet Money: A Guide to the Economic Forces That Shape Your Life - Our weekly longform Planet Money newsletter- Our weekly Indicator round-up newsletterFollow: - Instagram- TikTok- YouTube- FacebookSupport public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include bonus episodes and sponsor-free listening. Learn more at plus.npr.org.This episode of Planet Money was hosted by Erika Beras and Jeff Guo. It was produced by James Sneed with reporting help from Áine Pennello. It was edited by Jess Jiang, Sierra Juarez is our fact-checker, and Jimmy Keeley & Travis Hagen engineered the show. Alex Goldmark is the executive producer of Planet Money..
Animals Starves while the Kardashians Miss the Charts Again
(Welcome to my weekly streaming ratings report, the single best guide to what’s popular in streaming TV and what isn’t. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. If you were forwarded this email, please subscribe to get these insights each week.) Before we get going, I’d like to offer congratulations to Jonathan Funke, whose suggestion “midflicks” won the poll for what I should call straight-to-streaming films which aren’t big or cinematic enough to go to theaters but seem too expensive for a TV movie. It’s so useful a term, I just used it last week! Now I just need to add this term to my data dictionary! Okay, on to this week’s issue. We’re starting out looking at Netflix/Ben Affleck’s latest crime thriller, Animals. I’ll also look at Disclosure Day heading to Peacock (it did better than you’d remember in theaters...) and a new movie based on toys. Plus, a long-time streaming flop returns for its eighth season...will it finally chart? (No.) Will anyone at Disney care? Probably not. All that, plus another look at new shows landing on streaming on 1-Oct from Reelgood, what streamer hasn’t had a film make the Luminate charts since August, Reacher’s long run on the charts, M_onster: The Lizzie Borden Story’s_ short run, the top shows in 2026 according to Samba TV, all the flops, bombs and misses, and a whole lot more. And I mean that last part: putting this week’s issue together, I assembled OVER 25 images, most of which are bespoke looks I made just for this report. Really, publishing articles like this takes the work of writing two articles: one is the narrative and the other is making charts/graphs. Let’s dive right in! (Reminder: The streaming ratings report focuses on the U.S. market and compiles data from Nielsen’s weekly top ten viewership ranks, Luminate’s Top Ten Data, JustWatch and Reelgood interest data, Samba TV household viewership, company datecdotes, Netflix hours viewed data, Google Trends, and IMDb to determine the most popular content. While most data points are current, Nielsen’s data covers the week of October 5th to October 11th, 2026. You can find a link to my terminology here.) Subscribe Film - Netflix’s Latest Star-Studded Thriller Goes For Glory The tempting angle for anyone writing about streaming film this month, like yours truly, is to ask, “Is this why Dan Lin lost his job at Netflix?” Take Animals, the Ben Affleck-starring-and-directing, Artists Equity-produced crime thriller that opened on 9-Oct. (Kerry Washington and Gillian Anderson are also in it.) If it did really well, then one could argue that Lin has another success on his resume. If it underperformed, then it’s another example of a Netflix underperformance this year. So where did Animals fall? Kinda in the middle, but that means it’s more “not a hit” than “big hit”. On Nielsen, it opened to 12.0 million hours, and here’s how that stacks up for 2026 films so far this year: Obviously, that’s not great. It’s both under my 15 million opening bar for “fine” for a Netflix film and 20 million bar for “great” opening. It did a bit better on Samba TV, getting to first place. That’s very, very good, though again, looking at the Nielsen data, it probably means that it was a light week overall. Luminate’s data is a bit closer to Samba TV’s, tied for 17th all time for single weeks since May of 2024: To top it off, no one seemed to like it. It has a 33 on Metacritic and only a 5.7 on IMDb. Both of these numbers could have been impacted by the stories about Affleck’s comments about using AI to make the film. Given the controversy, the film might not have been as bad as the ratings suggest, but it’s also not a bullish sign. All to say…yeah, on net this film isn’t a point in Dan Lin’s favor. At this point, Netflix’s slide has been long enough—going on since February—that I’m almost tempted to lower the bar for what a “hit” is on streaming. Post-February of 2026 or so, it seems like straight-to-streaming films just haven’t hit the same heights as they did from 2022 to 2025. Before we head onto the “Quick Hits” for film, I want to shout out a fellow newsletter whose articles I’ve been loving this year, LA Material, a new LA-based news outlet. For just a highlight of my favorite articles since July... I loved this article on Ghost Town, a group on Venice that clears homeless encampments. As a Los Angeleno, obviously I adore their articles on LA parking issues. Their article on illegal parking tickets got the City Council to address the issue! Also check out their article on people parking in medians. Check out their deep dive on what went wrong with the LA Jazz Festival and how it fell apart, or what’s wrong with USC’s finances. Finally, they wrote up a voter guide on voter guides for the LA General Election. So meta! In search of a city? L.A. Material is an independent news outlet covering the people, politics, culture and glorious chaos shaping Los Angeles. L.A. Material brings you intel on the city you can’t get anywhere else. From exploring how Reddit short stories became Hollywood’s hottest commodity to reporting on the survival jobs keeping entertainment workers afloat. And answering, once and for all, why the AMC Burbank escalator is always broken. Through their newsletters, podcast, videos, events, and member community, L.A. Material is designed to help Angelenos connect to Los Angeles and each other. Sign up now for the free weekday newsletter. Quick Notes on Film Steven Spielberg’s latest film, Disclosure Day, came to Peacock on 9-Oct, and I’ll admit that, after pulling its stats, I did a pinch of a double take. As I wrote throughout my deep, deep, deep dive on summer box office/Obsession/Backrooms/IP/superheroes, oftentimes the film media discusses films as “flops” or “misses” or “hits” without clarifying what they specifically mean. Since Disclosure Day didn’t make $250 million in the US or $500 million globally, it was definitely a disappointment by Spielbergian standards, who is the highest-grossing director of all time, and arguably even more ahead in adjusted grosses. But it did make $245 million globally on a $115 million budget, so it isn’t as big of a miss as I remember. That’s still probably not enough to break even in the theatrical window, when you factor in marketing costs…but it’s close. And it grossed a lot more even in the US than some titles with about ten times more coverage. Anyways, lots of preamble to say this one only did 4.5 million hours according to Nielsen, so it did make the charts, but on the low end. Here’s how it stacks up to other Peacock titles: Apple TV (née +) followed up their “success for them” Mayday with Matchbox The Movie. This one doesn’t look like a success even for them, but at least it’s not a miss. Apple/Skydance clearly tried to take advantage of the success of Barbie at the box office—let’s greenlight all the toy properties!!!—but of course, this didn’t make it to theaters. And it stars John Cena, who, as I argued earlier this summer, NEEDS to get his movies back in theaters. Anyways, this one has mixed-to-bad numbers. It missed the Samba TV and Nielsen charts in its first week, but did make Luminate with 7.1 million hours. That’s just enough to not be an outright miss, and about half what Mayday did earlier this summer. Speaking of Apple Studio’s Mayday, it ended up lasting five weeks on Luminate, which isn’t bad for Apple TV. On Nielsen, it had a three-week run, racking up 13.5 million hours total. Again, like Matchbox, the issue is the budget; I doubt that this viewership earned enough to justify that budget. Also, to be clear, neither of these films are “midflicks”; both should have gone to theaters. Toy Story 5 is not hanging around on the streaming charts on Disney+, so it’s not as leggy as either Zootopia 2 or Moana 2, and definitely not in the same class as Encanto. (It did make all the money at the box office, so Disney is going to be fine…) The Breadwinner on Netflix (from Sony) is down to 3.9 million hours in its third week. It only lasted for one week on the Samba TV charts. Netflix’s Doing Life had a smaller-than-normal binge release curve bounce, only going to 7.1 million hours from 6.0 to start, but it made Samba TV at fifth place in its second week. The Netflix documentary, The Widower: Til’ Death Do Us Part, also had a small binge release curve bounce to 6.5 million hours, but did make a second week on Samba TV. Meanwhile, Netflix’s Unabomber fell off after two weeks on Nielsen—which is not great at all—and Demon Slayer fell off after just one week. Over on Luminate, the two smaller titles The Swan: Behind the Mirror and Kill. Bury. Print both fell out of the Luminate top ten charts. The story of library film at the first of the month is the arrival of the Ice Age films on Netflix. Now, here’s a small example of optimizing your library that even Netflix could do better. Say you want to rent/license a new film series from Disney**.** A streamer could pay a big paycheck and then drop each Ice Age film on the exact same day of the month, the fourth of October. That’s one choice. In contrast, the streamer could have released each film one week apart, and make each one a mini-event for folks watching Ice Age films. Or even roll them out monthly. Netflix opted for the former strategy, and as a result, only three of the films made the Nielsen charts this week. The “Miss of the Week” goes to Tubi’s YA-ish horror film_, R.L. Stine’s Pumpkinhead 2_, which didn’t even make the Luminate charts like Tubi films usually do, or, should I say, “used to”? Tubi films, most of which are straight-to-streaming, used to reliably make the Luminate film charts (which only covers straight-to-streaming films), but a Tubi film hasn’t made it since August. The first Pumpkinhead got 1.4 million hours last year according to Luminate. As I wrote about this film before, it seems to be a bit muddled in terms of age: too scary for young kids but probably not scary enough for older kids. Speaking of Luminate, Netflix’s latest doc about a comic (expect more docs about comedians all month), Who Is Martin Mull?, flopped, getting just 200K and 700K hours according to Luminate. Three other film/special misses belonged to Hulu, including a standup special, Jamie Foxx: Take Care of Yourself, Neon’s latest horror film, Hokum, which made $17 million in the US, and a Family Guy Halloween special. (That last one was only 22 minutes, so it’s not a surprise it missed.) Finally, another Netflix standup special missed the charts, Mojo Brookzz: I Know You Lying missed too. I can confirm last week’s misses, most notably Paramount+’s Jackass: Best and Last, MUBI’s Teenage Sex and Death at Camp Miasma and HBO Max’s Evil Dead Burn. Television - I Can’t Visualize Nothing: The Kardashians Story Normally, in the mini-dive essays that open the Streaming Ratings Report, I focus on shows that do well or, at the very least, make the charts. Why? Because as I’ve said time and again, I can’t visualize nothing like, say, the Kardashians’ TV shows. Here’s the TV debuts chart for this week with a missing spot for The Kardashians, whose eighth season just landed on Hulu:
Are the EU and Canada moving closer?
Many Canadians are rethinking their relationship with the US amid the trade war and political uncertainty. They are thinking twice about where products they buy come from. Should Canada look more to Europe?
Littler through as Van Gerwen suffers early Euros exit
World champion Luke Littler makes it through to the second round of the European Championship with a win over William O'Connor but Michael van Gerwen is knocked out of the tournament at the first-round stage.
Cutting ‘red tape’ is nothing but a red herring
Blaming a moribund economy on too many rules is a hackneyed neoliberal trope – UK plc needs smarter regulation, not less regulation
Nintendo joins Best Buy for midnight Zelda 40th Anniversary Switch 2 restock launch
📅 The Zelda 40th Anniversary Switch 2 releases on Thursday, October 27 🚨 Our Zelda Switch 2 restock tracker @mattswider on X will send out an alert when stock appears 😲 Nintendo Store held a surprise restock on October 26 and is holding a midnight launch event on November 5 🙏 Other retailers may be holding back stock for launch day, too Walmart: Zelda Switch 2 console Best Buy: Zelda Switch 2 console GameStop: Zelda Switch 2 console Target: Zelda Switch 2 console Nintendo: Zelda Switch 2 console 🚨 We’re tracking Zelda Switch 2 stock updates. If you’d like to know when more stock arrives, follow Matt Swider on X and turn on notifications. You can also become a free or paid subscriber to The Shortcut to help support our work. 🚨 🚨 Want the Zelda 40th Anniversary Switch 2? Drop your email for restock alerts before it sells out. ⤵️ Subscribe We’re expecting to see a Zelda 40th anniversary Switch 2 restock tomorrow at major retailers like Walmart, as the console and Pro Controller are set to launch. However, Nintendo has joined Best Buy in announcing a midnight launch event for The Legend of Zelda: Ocarina of Time on November 5, where limited quantities of the special edition console will be available. There is a catch, though. To attend the in-store event, which will be held on November 4 at Nintendo San Francisco and November 5 at Nintendo New York, a Warp Pipe Pass is required, which means capacity will be limited. If you’re lucky enough to receive a Warp Pipe Pass (they’re currently fully booked), you’ll be able to purchase The Legend of Zelda 40th Anniversary Edition console, Zelda 40th Anniversary Nintendo Switch 2 Pro Controller and display stand, the Zelda 40th Anniversary Switch 2 Pro Controller on its own, and the Zelda 40th Anniversary carrying case and screen protector. Purchases will be limited to one “per customer” and will be sold on a “first come, first served basis.” Why you should follow our Zelda Switch 2 restock tracker Obviously, many will be looking to receive the Zelda Switch 2 before November 5, and an instore event isn’t exactly ideal for many. That’s where our exclusive Zelda Switch 2 restock tracker comes in, as we’re providing up-to-the-second US store inventory checks. Those who follow Matt Swider on X and turn on notifications will be the first to know when new stock is live, as you can see in the post below. [ Matt Swider (The Shortcut)@mattswider ](https://x.com/mattswider/status/2114758291322757239?s=20) Zelda Switch 2 console in stock at the Nintendo Store nintendo.com/us/store/produ… 4:37 PM · Oct 26, 2026 · 67K Views 18 Replies · 4 Reposts · 75 Likes We’re strongly expecting retailers like Walmart to have stock on launch day, especially as it’s the largest retailer in the US. Cancellations can also occur in the run up to release, meaning more stock is made available that was previously taken. Thursday and Friday mornings is also when Walmart tends to offer restocks online. We’re predicting other retailers like Target, GameStop and Amazon will also get a new wave of consoles on launch day, and we’ll notify you if and when any Zelda Switch 2 restocks appear. You can trust our restock tracker as we helped over 400,000 people buy Sony’s console when it was in and out of stock for two years. We’ve since made it our goal to help our subscribers purchase hard-to-find items. We’ve done the same with the PS5 30th anniversary edition and many more in-demand products. Up next: Zelda 40th Anniversary Switch 2 Pro Controller restock looks increasingly likely at Nintendo Store Subscribe Adam Vjestica is The Shortcut’s Senior Editor. Formerly TechRadar’s Gaming Hardware Editor, Adam has also worked at Nintendo of Europe as a Content Marketing Editor, where he helped launch the Nintendo Switch. He also runs a retro gaming YouTube channel called Game on, boy! Follow him on X @ItsMrProducts.
High-level dialogue on One Health
On One Health Day, observed every year on 3 November, WHO/Europe will convene a high-level dialogue in Brussels with the Food and Agriculture Organization of the United Nations, United Nations Environment Programme and World Organisation for Animal Health, alongside European institutions, technical agencies and strategic partners.
Editorial: Another dozen reasons to vote ‘no’ on Amendment 3
If you’re still still considering whether to vote for Amendment 3 (which would eliminate non-school property taxes for almost every homesteaded property in the state, and give the Legislature far
Armando González Shows Humility; Greets Fans in Opposition Stadium
Skipping a rest day to support his teammates, Armando "La Hormiga" Gonzalez stunned spectators by mingling with the crowd, proving why the Mexican striker is Europe's rising star of character.
Zelda 40th Anniversary Nintendo Switch 2 restock signals good news for launch day buyers
📅 The Zelda 40th Anniversary Switch 2 releases on Thursday, October 27 🚨 Our Zelda Switch 2 restock tracker @mattswider on X will send out an alert when stock appears 😲 Nintendo Store held a surprise restock yesterday, which is good news for other retailers 🙏 It suggests other retailers may be holding back launch day stock, too Walmart: Zelda Switch 2 console Best Buy: Zelda Switch 2 console GameStop: Zelda Switch 2 console Target: Zelda Switch 2 console Nintendo: Zelda Switch 2 console 🚨 We’re tracking Zelda Switch 2 stock updates. If you’d like to know when more stock arrives, follow Matt Swider on X and turn on notifications. You can also become a free or paid subscriber to The Shortcut to help support our work. 🚨 🚨 Want the Zelda 40th Anniversary Switch 2? Drop your email for restock alerts before it sells out. ⤵️ Subscribe We predicted that a Legend of Zelda 40th Anniversary Switch 2 restock would happen on launch day, October 29, and we’re now even more confident after the Nintendo Store’s surprise restock yesterday. Our followers were the first to know that the Zelda Switch 2 was back in stock at the Nintendo Store, and the console even promised to arrive on launch day if you managed to secure one. [ Matt Swider (The Shortcut)@mattswider ](https://x.com/mattswider/status/2114758291322757239?s=20) Zelda Switch 2 console in stock at the Nintendo Store nintendo.com/us/store/produ… 4:37 PM · Oct 26, 2026 · 67K Views 18 Replies · 4 Reposts · 75 Likes It strongly suggests that other retailers such as Walmart, Target, GameStop, Amazon and Best Buy will have more units – albeit in limited quantities – on launch day for those who currently don’t have a pre-order. Retailers often hold back stock for launch day buyers who haven’t pre-ordered. Cancellations can also occur in the run up to release, meaning more stock is made available that was previously snapped up. Zelda Switch 2 restock – why Walmart will have stock Walmart historically holds back extra stock for launch day, and we’re expecting the same to happen on October 29. As the largest retailer in the US, it usually has the biggest stock allocation, and Thursday and Friday mornings is when the retailer tends to offer restocks online. As we mentioned previously, Nintendo was also a retailer to watch – and it went live with a restock earlier than we thought. It had previously promised the Zelda 40th anniversary Switch 2 would be “replenished”, and it offered a limited amount of stock for those who were lucky enough to snag one. (Hint: Followers of Matt Swider on X and our restock tracker were first in line.) We’re expecting other retailers like Target, GameStop and Amazon to get a new wave consoles on launch day, and we’ll notify you if and when any Zelda Switch 2 restocks appear. Why you should follow our Zelda Switch 2 restock tracker Remember when you couldn’t find a PS5 for nearly two years? Not our followers. We helped over 400,000 people buy Sony’s console when it was in and out of stock, and we’ve since made it our goal to help our subscribers bag hard-to-find times. We’ve done the same with the PS5 30th anniversary edition, Nintendo Switch 2, and many more in-demand products. With up-to-the-second US store inventory checks, The Shortcut and Matt Swider on X offers exclusive Zelda 40th anniversary Switch restock updates. You’ll also receive an instant notification on X (if set to on) as soon as new stock arrives. Up next: Zelda 40th Anniversary Switch 2 Pro Controller restock looks increasingly likely at Nintendo Store Subscribe Adam Vjestica is The Shortcut’s Senior Editor. Formerly TechRadar’s Gaming Hardware Editor, Adam has also worked at Nintendo of Europe as a Content Marketing Editor, where he helped launch the Nintendo Switch. He also runs a retro gaming YouTube channel called Game on, boy! Follow him on X @ItsMrProducts.
Sergio Garcia And European Legends Face Permanent Ryder Cup Ban
European golf legends who left for LIV Golf remain barred from Ryder Cup captaincy under a 2017 rule, blocking their return despite recent exits.
Republican billionaire Rick Jackson is walking a Trump tightrope in his quest to lead Georgia
Rick Jackson wants to be Georgia's governor and the Republican billionaire is promising to fight for working-class voters.
Recent health inspections reveal Novi restaurant woes
Oakland County health inspectors found drain flies and improper food storage at several Novi restaurants recently.
Trump’s Ukraine Moves and Middle East Tensions Have Europe on Edge Ahead of Elections
As Americans head to the polls, many people in both Europe and the Middle East are on edge, wondering how the midterm elections may shape U.S. foreign policy in the weeks and months to come. While much of the attention domestically has focused on fuel prices and the cost of living, President Donald ...
Alexandria culls life science holdings as industry recovers from development glut
Company sells properties or partial stakes in key markets like Boston and San Diego
Zelda 40th Anniversary Switch 2 Pro Controller restock tracker: we’re watching these retailers
🎮 Nintendo will release a Zelda 40th anniversary Switch 2 Pro Controller on October 29 💰 It costs $99.99, the same as other limited editions 📅 A restock could occur on launch day at Walmart and Best Buy 🚨 Our Zelda Switch 2 Pro Controller restock tracker @mattswider on X will send out an alert when stock appears Walmart: Zelda Pro Controller Best Buy: Zelda Pro Controller Amazon: Zelda Pro Controller Target: Zelda Pro Controller GameStop: Zelda Pro Controller Nintendo is releasing a special limited edition Nintendo Switch 2 Pro Controller to celebrate the 40th anniversary of The Legend of Zelda series. It releases on October 29, 2026, which is when we expect to see a long-awaited restock of the hard-to-find controller. 🚨 We’re tracking Zelda Switch 2 Pro Controller stock updates. If you’d like to know when more stock arrives, follow Matt Swider on X and turn on notifications. You can also become a free or paid subscriber to The Shortcut to help support our work. 🚨 The Switch 2 Pro Controller features the same striking gold and royal emerald color scheme of the Nintendo Switch 2 The Legend of Zelda 40th anniversary edition, and also includes a fun little easter egg on the back: an 8-Bit Link. 🚨 Want the Zelda 40th Anniversary Switch 2 Pro Controller? Drop your email for restock alerts before it sells out. ⤵️ Subscribe This is the same Nintendo Switch 2 Pro Controller we’re used to, aside from the intricate design, but it means you’ll have to pay more as a result. It costs $99.99 instead of the standard $89.99. However, the Pro Controller is the easiest way to play the best Switch 2 games in TV mode. If you’ve been searching for a Zelda 40th Anniversary Switch 2 Pro Controller restock, here’s everything you need to know. Zelda 40th anniversary Switch 2 Pro Controller should restock at these retailers We’ve seen retailers such as Walmart and Best Buy restock items on release day, even when pre-orders have sold out. It’s likely that the Zelda Switch 2 Pro Controller will be up for grabs on October 29, 2026, when the controller and console launches. Demand will be high, and stock could sell out fast. However, we’ll be keeping a close eye on every major retailer, including Target, Amazon, GameStop, and the Nintendo Store and will alert our followers as soon as stock goes live. Why you can trust our Zelda Switch 2 Pro Controller restock tracker We’ve already helped over 400,000 people buy a PS5 when it was in and out of stock during Covid, and we’ve helped our subscribers continue to secure hard-to-find items. The Shortcut followers were some of the first to secure the Switch 2 when it went on sale, and we’ve also helped countless others snag limited edition consoles like the PS5 30th anniversary edition. The Shortcut and Matt Swider on X offer exclusive Zelda 40th anniversary Switch 2 Pro Controller restock updates with up-to-the-second US store inventory checks at the biggest retailers. You’ll receive an instant notification on X (if set to on) as soon as new stock arrives. Up next: Call of Duty: Modern Warfare 4 review roundup: ‘a strong return to form’ Subscribe Adam Vjestica is The Shortcut’s Senior Editor. Formerly TechRadar’s Gaming Hardware Editor, Adam has also worked at Nintendo of Europe as a Content Marketing Editor, where he helped launch the Nintendo Switch. He also runs a retro gaming YouTube channel called Game on, boy! Follow him on X @ItsMrProducts.
Scientists uncover new way to control magnetism and topology using light in atomically thin materials
Envision a material whose magnetic properties and electronic topology can be toggled by exposure to light, paving the way for future electronic devices that do not rely on traditional electrical switching, ...
Texas Athletics and McCombs’ Business of Sports Institute Launch Bevo Lab for Sports AI and Analytics
University of Texas Athletics and the Business of Sports Institute (BOSI) in the McCombs School of Business, in cooperation with Longhorn Sports Properties, have launched Bevo Lab, a platform that...
Caesars Entertainment to offer free self-parking at properties through Christmas
Free parking at 8 Las Vegas properties plus discounts on dining, spa and shows.
Dentists share oral health tips ahead of Halloween as National Brush Teeth Day approaches
With Halloween just days away and many children preparing to enjoy candy, local dentists are reminding families about the importance of proper brushing and oral health during National Dental Hygiene Month.
Notes from the IAPP Europe: Digital Omnibus progress, health data and online scams and fraud
Recent EU policy developments include the Council of the EU's adoption of its negotiating position on the Digital Omnibus package, progress on implementing the European Health Data Space and increased Digital Services enforcement.
Brewers' Biggest Winners and Losers from World Series Game 1
Jackson Chourio’s clutch hitting and William Contreras’s defensive masterclass propelled the Milwaukee Brewers to a gritty series-opening win.
Hard-working business site is transformed into sustainable home
Flat Tire Farms is on property in Pendleton once used for hay, old cars and annual barbecues for customers
The global stakes of France’s political and fiscal crisis
Experts discuss what the crisis means for France's upcoming elections as well as Paris's role in defending Europe and supporting Ukraine.
ESMO: Roche touts ‘convincing’ phase 3 KRAS data after win over rivals
Roche has shed more light on its investigational KRAS G12C inhibitor's phase 3 victory over Amgen’s Lumakras and Bristol Myers Squibb’s Krazati. The open-label Krascendo 1 trial enrolled 338 people with previously treated KRAS G12C-mutated non-small cell lung cancer (NSCLC). Patients who had already received a KRAS G12C inhibitor or pan-KRAS/RAS inhibitor were excluded from the trial. Participants received either divarasib once daily, Lumakras once daily or Krazati twice daily. Roche announced back in July that divarasib had demonstrated statistically significant improvements in progression-free survival (PFS) and overall survival (OS), meeting the trial’s primary and key secondary endpoints. But the Swiss pharma had been holding back the detailed data until now. At the European Society for Medical Oncology (ESMO) Congress in Madrid, Roche revealed that median OS for the 167 patients who received divarasib was 17.7 months, compared to 12 months for the 171 patients who received Lumakras or Krazati. The benefit was similarly clear when it came to median PFS, which stood at 9.8 months versus 5.7 months, respectively. A total of 44% of patients receiving divarasib were alive without disease progression at one year, compared to 24% of the control group, according to Roche’s presentation. It was a similar story for the objective response rate, which came in at 58% for divarasib versus 32% for the control group, while median duration of response was 11.9 months versus 6.9 months. Stefan Frings, M.D., Ph.D., deputy chief medical officer at Roche Pharma, told Fierce that the data made for a “very comprehensive, strong package, which should be convincing to health authorities.” “It’s an important advance for patients with lung cancer,” Frings said in an interview at a Madrid hotel during the conference. “It's a second-line setting, and patients who receive divarasib benefit compared to the current first-generation KRAS G12C inhibitors by having far longer overall survival,” he continued. “They live longer. They have better progression-free survival, better response rates, and with a safety profile which is—if [anything]—even better,” he said. According to Roche, 4.8% of patients receiving divarasib discontinued treatment due to treatment-related adverse events, compared to 11.7% in the control group. Serious treatment-related adverse events were also less common with divarasib, at 7.8% versus 15.2%. Roche’s confidence in divarasib had been building even before this phase 3 success. The candidate had already shown better potency and selectivity than the incumbent KRAS G12C inhibitors Krazati and Lumakras in preclinical tests. After cross-trial comparisons suggested that the edge translated into better clinical outcomes, Roche axed a study comparing divarasib to the chemotherapy docetaxel and went toe-to-toe with Lumakras and Krazati. “We designed the drug on purpose with higher potency and better selectivity,” Frings explained. “So, based on preclinical models, we clearly knew it would be superior to the first generation.” “It’s honestly not so frequent that pharma companies go head-to-head,” he added. “But if you want to make a point, if you want to convince payers, prescribers and patients … then a head-to-head win is rather rewarding.” While Amgen and BMS reached the regulatory finish line first for KRAS G12C-mutated, locally advanced or metastatic NSCLC in 2021 and 2022, respectively, they have struggled to capitalize on their head start. Krazati brought in $55 million for BMS in the second quarter, while Lumakras delivered $111 million to Amgen. For its part, Roche is aiming for peak divarasib sales of 1 billion to 2 billion Swiss francs ($1.2 billion to $2.5 billion), according to Frings. The Big Pharma is currently recruiting patients into a phase 3 trial comparing divarasib plus Keytruda against Keytruda plus chemotherapy in previously untreated advanced or metastatic nonsquamous KRAS G12C-mutated NSCLC. Roche has previously suggested that sales in metastatic disease would account for most of the forecast. Frings was tight-lipped on the exact timeline for a regulatory filing but said the Swiss pharma is “certainly keen to get this to as many patients as possible around the world.” Roche has more RAS drugs coming up behind divarasib. The pharma has already launched phase 1 trials of a pan-RAS inhibitor called RG6505 and a KRAS G12D inhibitor dubbed RG6620 in solid tumors. Roche’s partner Chugai Pharmaceutical is also testing a pan-KRAS inhibitor called AUBE00. Roche has made a “deliberate effort” to test a range of RAS drugs, Frings said. “If you have many rare mutations and you are scrambling to find sufficient patients, a pan-RAS inhibitor makes a lot of sense,” he explained.
Sikorski: Musk Should Fly to Mars, Avoid Mixing Business and Politics
Polish Foreign Minister Radosław Sikorski warned Elon Musk against mixing business with politics, emphasizing that Europe holds cards in peace talks.
Hibernian vs Celtic – Match preview and team news
Celtic will look to bounce back from their recent European defeat as they travel away from home to face Hibernian in their next Scottish Premiership match on Sunday.Hibernian vs Celtic – Match prev...
Amendment 3 gains favor, races tighten and execution pace: Podcast
Why some voters say they want that property tax cut and what our audience thinks of the state's potential record year in death row executions.
Who Owns What: The Watermania Waterpark Richmond May Expropriate
[There is often a lack of transparency around land ownership in BC. Who Owns What is an ongoing series by The Realist focused on interesting land ownership stories. Have a suggestion for a future story? Email: howardchai@substack.com.] Earlier this month, CBC and Richmond News reported that the City of Richmond is planning to expropriate Watermania, the waterpark located at 14300 Entertainment Boulevard near the Richmond Ice Centre. The City of Richmond currently leases the property from a private owner — 14300 Entertainment Blvd. Investments Ltd. — and the lease is set to expire in March 2027. According to the reports, the two sides have been unable to agree on terms of the lease renewal and the City has since served a Notice of Expropriation, saying it wants to secure “essential community services,” according to CBC, with outgoing Mayor Malcolm Brodie telling CBC that “Watermania is an important recreation facility for our community, and the city’s goal is to secure its long-term future.” Richmond News added that because the expropriation is not for a linear easement like a sewage line or rapid transit, an inquiry can be requested, and one has been scheduled for November 30 to December 4, according to CBC. What was left out of both stories, however, is who the City would be expropriating Watermania from. According to the Land Owner Transparency Registry, 14300 Entertainment Boulevard is legally owned by 14300 Entertainment Blvd. Investments Ltd. and that numbered company is controlled by a Chinese individual named Hai Feng Zhu, who primarily resides in the Jilin province. The registered address of 14300 Entertainment Blvd. Investments Ltd. is 3899 Cartier Street in Vancouver, a mansion in Shaughnessy that BC Assessment values at $10,423,000. The home at 3899 Cartier Street has previously been tied to Kevin Sun of Sun Commercial by reporter Sam Cooper when he was with the Vancouver Sun in a report noting that Sun had an associate named Hai Feng Zhu who is a director of SunOil Ltd., as confirmed by the company’s filings. Another person mentioned in both the report and filing is Denise She. A search of Hai Feng Zhu in the Land Owner Transparency Registry reveals that Zhu also owns four other properties in British Columbia. The Realist then used the PIDs1 to identify the addresses, finding that the two parcels with PIDs beginning 014 are two parcels that form 1155 Bidwell Street in Vancouver and that the two parcels with PIDs beginning 015 are two parcels that form 1755 Davie Street. 1755 Davie Street is the Best Western Plus Sands, 1155 Bidwell Street is a surface parking lot, and both are held under 0993956 B.C. LTD., which is controlled by Hai Feng Zhu alongside the aforementioned Kevin Sun and Denise She, among others. The Best Western Plus Sands is listed under Sun Commercial’s portfolio and Sun Commercial also previously sold the Richmond Ice Centre to the City of Richmond for $32 million in 2019. Denise She, Peter Cheng De She, and Julia MiMi Yang also control 1078635 B.C. Ltd., which owns 1707 Davie Street, the small retail building that sits between 1755 Davie Street and 1155 Bidwell Street. Governments in British Columbia have a tendency to overpay for real estate, so it’ll be interesting to see how much the City of Richmond pays for Watermania if they do end up expropriating the property. BC Assessment values 14300 Entertainment Boulevard at $49,397,000. The assessed value is dated to July 1, 2025 and is a small decline from the previous assessment of $52,584,000. The rest of this story dives into Sun Commercial and $159 million in sales it made last year to KingSett Capital. Become a paid subscriber for all the details. Subscribe Sun Commercial Sun Commercial is based out of the City Square Shopping Centre at 555 W 12th Avenue in Vancouver, which it acquired in 2019 for $225 million, and also has an office located at 415 Yonge Street in Toronto.
Cheesecake Factory's longtime designer calls Obama White House jab 'pettiness of politics'
Trump fired back on Monday, defending his renovations and design choices while accusing Obama of failing to properly care for the historic residence.
Public Health Command Europe laboratory earns renewed accreditation, strengthens force health protection
LANDSTUHL, Germany — Public Health Command Europe’s Laboratory Sciences Division has renewed its accreditation, reaffirming its ability to deliver relia...
Franciscan Health, Tonn and Blank Plan Michigan City Medical Office Building at Former Marquette Mall
Franciscan Health, in partnership with Tonn and Blank Construction, is planning a medical office building on a portion of the former Marquette Mall property. Franciscan Health plans to operate a …
Nestlé and BirdLife Europe & Central Asia partner to measure how regenerative agriculture practices support biodiversity
A science-led collaboration will use farmland birds as trusted indicators of biodiversity.
Construction begins on Kading Properties' new headquarters
Construction is underway on Kading Properties’ expansion of its Urbandale headquarters as it prepares for future growth and celebrates its 50th year in business this year, the company’s CEO said. Kading, which focuses on construction of workforce housing statewide, is building an 11,000-square-foot building on its current lot at 7008 Madison Ave. and an adjacent parcel…
Ioanna Nixon: Improving Cancer Care Through Science, Innovation and Partnership at ESMO 2026
Ioanna Nixon: Improving Cancer Care Through Science, Innovation and Partnership at ESMO 2026 / cancer, cancer care, ESMO, esmo 2026, European Society for
Property owners invest in resilience, but insurers slow to recognize efforts
Commercial property owners are investing in resilience measures, such as roof upgrades, automatic sprinklers and water-monitoring technologies, but insurer recognition of those efforts is still…
Middlesex Health faces class-action lawsuit over time-keeping policies, unpaid wages
A former Middlesex Hospital employee has filed a class-action lawsuit alleging the health system failed to pay workers properly.
Motorola Signature 27 and Razr Flex show up at a European retailer with prices
The Razr Flex has a very odd description, and a rather unrealistic price. Motorola showed off the Signature 27 at Qualcomm's Snapdragon event last month,...
New York investor snaps up large industrial site in Ravenna
Diamond Properties followed up its September acquisition of a site in Brunswick with an even larger purchase of a nearly fully occupied site near State Route 14 in Portage County.
Can GE Vernova's Gas Turbines Make Up for a Collapsing Wind Business?
It's a red flag investors would rather not see waving, but most of them may not have put this shift in its proper perspective.
Cheesecake Factory's longtime designer calls Obama White House jab 'pettiness of politics'
Trump fired back on Monday, defending his renovations and design choices while accusing Obama of failing to properly care for the historic residence.
Republican billionaire Rick Jackson is walking a Trump tightrope in his quest to lead Georgia
Jackson’s path differs from Donald Trump’s, and the 72-year-old healthcare magnate and investor brings a vastly different persona to his first campaign. Unlike Trump, who was born to wealth, Jackson spent his early years bouncing through foster homes before launching his first company as a young man.
Colorado small businesses will suffer is this tax proposal goes through: Cheryl Casone
'The Big Money Show' discusses Florida's proposed property tax reform. The panel also analyzes Colorado's controversial ballot measures that could raise taxes.
Cam Heyward roasts Steelers QBs over European Peaky Blinders outfits
Cameron Heyward called out Pittsburgh Steelers quarterbacks for excluding the defense from their coordinated Peaky Blinders suits in Paris.
Far right’s breakthrough year in Germany
Panelists at the Center for European Studies weigh what AfD’s rise means for German politics
Stevie Wonder sues to evict reported ex-fiancée from L.A. property
Stevie Wonder is taking legal action against a reported ex-fiancée, seeking to evict the woman after she has allegedly lived more than 30 years rent-free at the singer's Hollywood property.
Aston Villa and Man City kick off Saturday's PL action
2026-10-24T10:11:48ZFirst up, it's Aston Villa hosting leaders Manchester City. Both clubs head into the early match on the back of resounding midweek wins in Europe. Team news is just around the corn...
Caesars Entertainment records stronger regional casino growth than with Vegas properties
Caesars Entertainment NASDAQ:CZR traded flat in postmarket action as investors sized up the casino operator's third-quarter earnings report.Revenue was up 2.4% compared to a year ago at $2.94B to miss the consensus estimate by $20M. Regional casinos saw a 5.9% increase in revenue during the quarter…
30,000-year-old bone found in French cave reveals vast genetic connections between people of Eastern and Western Europe during the Stone Age
Scientists sequenced the genome of a woman who lived 30,000 years ago and discovered that she had mixed Eastern and Western European ancestry.
Global Health & WASH
The US National Institutes of Health reopened its center and program-project machinery in force. NIGMS is funding Collaborative Program Grants for interdisciplinary teams, NIAID opened both its Immune Tolerance Network and a next-generation R&D call, the NCI runs its Carcinogen Hazard Assessment Monographs program, the National Library of Medicine is funding institutional training in biomedical AI and data science, and NIH reopened its Centers for AIDS Research. The tell: these pay for standing centers and multi-year consortia at institutions with an existing funded research base, not one-off projects, so the fit is an established US research institution, not a single investigator. Disease-specific foundations are again funding the researcher, not just the research. The Parkinson’s Foundation opened its Paul Oreffice Innovations in Care Award and the National Ataxia Foundation its Research Seed Money Grant. The tell, the same one we flagged last cycle, is a named early-career or seed award that builds a pipeline of scientists committed to one condition, so what wins is a researcher willing to specialize. The post-USAID global-health money is routing through a State Department program statement and multilateral innovation funds. The US Department of State’s Bureau of Global Health Security and Diplomacy opened its Advancing Global Health Annual Program Statement, Grand Challenges Canada opened Nexa Lighthouse for climate and health innovation in Asia and the Pacific at USD $250,000 to $2,000,000, and CEPI opened a rolling call on vaccine-manufacturing analytics. The tell: the largest health money this cycle sits in a standing program statement and in staged innovation vehicles, not in a single bilateral grant. Total Estimated Funding Pool: ~$35.4M across discrete grants. (Separately, large national-formula envelopes not counted in this total: U.S. Department of State, Bureau of Global Health Security and Diplomacy (GHSD).) This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. New opportunities: Paul Oreffice Innovations in Care Award, Parkinson’s Foundation. *New!* *Closing soon!* The Parkinson’s Foundation created the Paul Oreffice Innovations in Care Award to fund clinicians rethinking how people with Parkinson’s disease receive care. The Foundation is using pilot funding to move promising ideas into testable projects, backing work across four lanes: strengthening community clinician capability, redesigning care models, building patient-centered technologies, and defining the minimum clinical datasets that make better standards possible. It wants hypothesis-driven, clinically grounded projects that can generate evidence strong enough to attract further funding. By opening the door to clinicians at every career stage and strongly preferring projects that involve people with Parkinson’s in their design, the Foundation signals that it values practical, patient-shaped innovation over prestige. The strongest fits are US-licensed clinicians with a focus on Parkinson’s and an institutional home for applied care research. Geographies: united states. Who can apply: Clinicians of all career stages, from fellows to established faculty, who are licensed to care for patients in the United States and have a significant focus on Parkinson’s disease. Physicians must have completed a neurology residency (or justify how their training pathway benefits people with PD); allied health professionals must hold an advanced degree, typically a PhD. Fellows, those in mentored positions, and those within two years of starting an independent position require a mentor and a mentor support letter. The sponsoring institution’s grants office is the authorized recipient and funds are disbursed to the institution. Funding amount: Maximum of $200,000 over two years; up to three awards. Targeted Sectors / SDGs: Health; Innovation; Science & Technology. Deadline: November 1, 2026. Learn more and apply here. Design and Deliver the Next EIT Health Bootcamps, EIT Health. *New!* *Closing soon!* EIT Health is opening its call for consortia to design and deliver the next generation of its health start-up bootcamps, funding the curriculum, masterclasses, mentoring, and investor engagement that turn early health ventures into fundable companies. The organization is using these learning paths to strengthen Europe’s health innovation pipeline across digital health evidence, deep tech and AI commercialization, cross-border investment, and patient access. What EIT Health wants to back is not a single course but durable delivery capacity built by partners who span industry, education, and research. Requiring multi-country consortia and a revenue-sharing stake in the programs signals that EIT Health expects these bootcamps to outlast the grant. The strongest fits are established training providers, universities, and industry partners with proven reach into health entrepreneurs. Geographies: Europe. Who can apply: Consortia only (individuals cannot apply), comprising a minimum of two and a maximum of five independent legal entities. Partners must cover at least two sides of the Knowledge Triangle (industry, education, research), including at least one industry organisation, and at least two entities must be legally established in different Horizon Europe countries. Funding amount: Foundational Learning Path: up to EUR €112,000; Thematic Learning Paths: up to EUR €124,500 per path (up to four thematic projects); up to EUR €610,000 total EIT Health funding available under the call. Targeted Sectors / SDGs: Health; Innovation; Science & Technology; Economic Development & Livelihoods. Deadline: November 2, 2026. Learn more and apply here. Technology Transfer Offices & Entrepreneurship Support Call (Beyond the Lab: From Research to Venture), EIT Health. *New!* *Closing soon!* EIT Health is opening its Technology Transfer Offices and Entrepreneurship Support Call to fund consortia that will deliver the Beyond the Lab: From Research to Venture program for healthcare researchers. EIT Health is using the grant to build local capacity for turning laboratory science into incorporated start-ups, paying experienced technology transfer offices and entrepreneurship support providers to run masterclasses, structured mentoring, and a closing Pitch Day across two cohorts. It wants to back organizations that can walk researchers from discovery to company formation, not just teach theory. Requiring two transfer offices plus one venture-building provider signals that EIT Health values proven commercialization experience alongside academic reach. The strongest fits are European research-commercialization teams with a track record of moving health innovations toward investable ventures. Geographies: Europe. Who can apply: A consortium of two Technology Transfer Offices (representing higher education institutions or research organisations) and one Entrepreneurship Support Provider with demonstrated experience in venture building and start-up support. Applicants may apply for more than one learning path where they can demonstrate the required expertise and capacity for each. Funding amount: Up to EUR €77,000 in 2027 and up to EUR €77,000 in 2028 (up to EUR €154,000 total per consortium over two years). Targeted Sectors / SDGs: Health; Innovation; Science & Technology; Economic Development & Livelihoods. Deadline: November 2, 2026. Learn more and apply here. EIT Health RIS Country Representatives Call (2027-2028), EIT Health. *New!* *Closing soon!* EIT Health is seeking organizations to serve as Country Representatives across eleven Regional Innovation Scheme countries in central and eastern Europe for the 2027 to 2028 period. The money funds a national anchor in each country, an organization that maps the local health innovation ecosystem, connects startups and researchers to EIT Health programs, and builds the stakeholder relationships that let health ventures grow. EIT Health is backing local capacity rather than individual projects, which is why it accepts both single organizations and national consortia that span education, research, and industry. The requirement for co-financing signals that it wants representatives already embedded in their national systems. The strongest fits are established ecosystem builders with deep ties to health innovation stakeholders in one eligible country. Geographies: Croatia; Czech Republic; Estonia; Greece; Hungary; Latvia; Malta; Romania; Serbia; Slovenia; Turkey. Who can apply: Registered legal entities established in one of the eligible EIT RIS countries. Single organisations or national consortia may apply. Consortia must include at least two sides of the Knowledge Triangle (education, research and industry), and all consortium partners must be established in the same eligible country. Suitable applicants have demonstrated experience in healthcare innovation ecosystem development, innovation support and entrepreneurship, start-up acceleration, technology transfer, research and higher education, business support, and stakeholder engagement, with strong links to national innovation stakeholders. Funding amount: Up to EUR €182,000 per Country Representative (maximum funding per project); total call budget up to EUR €1,274,500; EIT Health funds up to 60% of total eligible project costs. Targeted Sectors / SDGs: Health; Innovation; Science & Technology; Economic Development & Livelihoods. Deadline: November 2, 2026. Learn more and apply here. Architects of Trust: Community-Driven Demand Creation for New TB Vaccines, Treatment Action Group (TAG). *New!* *Closing soon!* Treatment Action Group, with funding from Wellcome, is opening its Architects of Trust call to help communities prepare for the new tuberculosis vaccines now moving through late-stage trials. The money backs civil society and community-based organizations to raise awareness, surface local questions and concerns, and press policymakers toward equitable national rollout. By pairing each grantee with an advocacy mentor and running a strategy workshop alongside the Global TB Vaccine Forum, Treatment Action Group is building a durable advocacy bench rather than funding one-off outreach. The two-stage design, starting with a short expression of interest, signals that fit and community rootedness matter more than polished proposals. The strongest fits are locally trusted groups with real TB, immunization, or health advocacy experience and a committed project lead. Geographies: Brazil; Ethiopia; India; Indonesia; Kenya; Malawi; Mozambique; Nigeria; Peru; Philippines; South Africa; Tanzania; Vietnam; Zambia. Who can apply: National, subnational, or regional civil society organizations (CSOs) or community-based organizations based in one of the 14 eligible countries or in Eastern Europe/Central Asia regional networks, with experience in TB, immunization, or other health advocacy and in community engagement or policy advocacy; well integrated into stakeholder networks with membership or affiliation to other CSO or community networks; naming a dedicated project lead (’architect of trust’) who can attend the April 2027 Zaragoza forum in person; and holding (or committing to adopt) organizational policies on safeguarding (bullying, harassment, abuse, and harm), equity, diversity and inclusion, and legal compliance, research practice and governance. Funding amount: Grants of up to US$45,000 will be awarded to 8 CSO partners across 14 high-TB-burden countries plus regional networks in Eastern Europe and Central Asia; each grant funds 12 months of work. Targeted Sectors / SDGs: Health; Governance; Policy & Advocacy. Deadline: November 4, 2026. Learn more and apply here.
HYDRINITY Accelerated Skin Science Announces Expansion into Spain Through Strategic Partnership with UniSthetic
HYDRINITY Accelerated Skin Science, the fastest-growing professional skincare brand in the U.S., announces its expansion into Spain through a strategic partnership with UniSthetic, a leading provider in the country's professional aesthetics and skincare industry. This partnership marks another significant milestone in HYDRINITY's continued global growth, introducing its portfolio of clinically backed, advanced regenerative skincare solutions to one of Europe's most established medical aesthetics
Cheesecake Factory's longtime designer calls Obama White House jab 'pettiness of politics'
Trump fired back on Monday, defending his renovations and design choices while accusing Obama of failing to properly care for the historic residence.
Business News: Audemars Piguet Unveils 'The Watch Keepers' - A Digital Platform Offering Certified Pre-Owned Watches
The Le Brassus watchmaker will facilitate sales and auctions of brand-certified timepieces on a digital platform launching in Switzerland and Europe, with plans for expansion to other markets, including the U.S.
Win Against Crystal Palace Lifts Newcastle Into The Top Eight
Matthias Jaissle’s men silenced critics at Selhurst Park, securing a vital clean sheet and two clinical goals to snap their away-day hoodoo and ignite European ambitions.
Champaign County Board members can no longer sign NDAs regarding county business
The Champaign County Board passed an ordinance banning board members from signing non-disclosure agreements. The Board also passed a resolution banning property tax breaks for data center developers.
Niagara Falls business admits to illegally storing hazardous waste
BUFFALO, N.Y. (WIVB) — A Niagara Falls business has admitted to illegally storing hazardous waste at a property on Highland Avenue, the United States Attorney’s Office said Monday. JEMF…
Game Time Thread: Juventus vs. Lecce
MATCH INFO When: Sunday, Oct. 25, 2026. Where: Stadio Via del Mare, Lecce, Italy. Official kickoff time: 6 p.m. local time in Italy and across Europe, 8 p.m. in the United Kingdom, 1 p.m. Eastern time, 12 p.m. Central time, 10 a.m. Pacific time. (Please note that the fall time change in Italy goes into effect on Sunday, […]
Alexandria Real Estate Equities to Sell Fenway Life Science Property at 421 Park Drive in Boston
BOSTON— Alexandria Real Estate Equities has agreed to sell its development property at 421 Park Drive in Boston’s Fenway neighborhood to an institutional buyer, a transaction expected to generate significant […]
Why Anthropic’s IPO is risky business
Ahead of Anthropic's IPO, the AI giant's S-1 outlined an unusually broad series of risks to the AI company's success including cyber threats, existential risks to humanity, the model's self-preserving qualities, a tumultuous political climate and even climate change. CNBC's Jonathan Vanian has the story.
Caesars Entertainment records stronger regional casino growth than with Vegas properties
Caesars Q3 earnings missed estimates as Las Vegas revenue fell and losses widened amid its pending buyout.
HHS Finalizes HTI-5 Deregulatory Rule to Encourage Innovation and Reduce Health IT Certification Program Compliance Costs
HHS released the Health Data, Technology, and Interoperability: ONC Deregulatory Actions to Unleash Prosperity (HTI-5) Final Rule.
Other Voices: In Ilhan Omar case, follow the evidence, not the politics
“The proper standard is plain: investigate credible evidence, protect due process and bring charges only if the evidence supports them. If Omar’s records are truthful, the inquiry should clear her. If investigators can prove o…
Scientists Estimate That Europe's Scorching Summer Heat Killed More Than 50,000 People in Urban Areas
The new research, which has not yet been peer-reviewed but was accepted for publication, suggests that climate change is responsible for two-thirds of the deaths
Living comfortably in Europe: How much net income do you need?
Living comfortably means different things to different people. Euronews Business calculated the monthly net household income needed to reach 150% of the national median which is the starting point of the upper-middle class benchmark.
Trail Blazers Start Season 2-0 After Win Over Kings
A lethal 44-point third quarter propelled Portland past Sacramento, proving this deep roster can overcome defensive lapses and halftime deficits to remain perfect in the Western Conference.
Photo Essay: College of Science and Engineering Research Showcase
Fourth-year Mechanical Engineering major Jess Visaya and Fourth-year Mechanical Engineering major Dorette Pirie show off their soft robots. The robots are made to mimic worms, whose bodies bunch up before extending to propel themselves forward. The robots use pneumatic actuators to make linear movement outwards. Visaya and Pirie set up two of their worms with syringes attached to tubing which was then threaded through the end cap into the worms. Visitors to their station were encouraged to race the two worms by pumping the attached syringes. Third-year Biochemistry major Ira Evetts worked in Dr. Christopher Whidbey’s lab studying the vaginal microbiome, in an attempt to better understand the different microbes that build it up and how it affects health outcomes. Evetts’ research was specifically focused on lactobacillus iners, one of several bacteria naturally present in a healthy vaginal microbiome, and methylation systems. Fourth-year Mechanical Engineering major John Diesko Boehm and Fourth-Year Mechanical Engineering major Ian Agopsowicz hold up their “DAQMobile.” They built their project, a modified RC kit car, to help teach mechanical engineers about circuits and electrical design through real-world application. Fourth-year Mechanical Engineering major Ben Murphy holds up his mole crab and crawfish-inspired burrower. Murphy wanted to imitate the motion of a crab’s legs through robotics, with the primary goal to “turn the rotation of one motor into four alternating legs that would successfully displace soil.” Murphy was inspired by works that take inspiration from the natural world, and he found mole crabs particularly interesting. Although a mole crab is at an advantage with its burrowing being underwater, thus the sand being fluidized and easier to displace, Murphy’s machine is able to successfully burrow three centimeters into the ground. Second-year Mechanical Engineering major and Physics major Arabelle Miller shows off her rubber gripper, inspired by kirigami and origami. She took a piece of rubber and strategically cut slits into it to make it fold the way she needed, then glued googly eyes to the front. The gripper is able to hold up to 38 times its weight, or 226 grams. Third-year Mechanical Engineering major Joonseong Park talked about how his project took an unused and broken 3-D printer and transformed it into a testing platform for soft robotic grippers. The former-printer was reprogrammed and had its extruder part modified to be a mount for the grippers. Park shows off some of the other grippers that can be attached to the testing platform. Park classified grippers into two large categories. The first set of grippers is designed to deal with small delicate objects with great precision, and the second is made to lift heavy or large objects. Third-year Mechanical Engineering major Jiashuo Liu set out with a goal to deploy free open-source AI models to pre-existing robots to integrate object recognition and retrieval and command. The models are used to process the data received from the robots’ cameras in order to detect certain objects and their locations. Fourth-year Mechanical Engineering major Cole Purohit focused on agricultural automation of raspberry picking. His project utilizes kirigami to make grippers to close around a raspberry when the two ends are pulled. “Nobody wants to eat a squished raspberry,” Purohit said. Fourth-Year Biochemistry major Mariel Nolan’s project focused on bacteria and proteins within the bacteria whose functions are unknown. Nolan’s research is finding a way to isolate those proteins with the ultimate goal of determining their functions. Fourth-year Mechanical Engineering major Kai Boydon and Fourth-year Mechanical Engineering major Evan Nguyen show off their project, which uses custom extensors to help with the rehabilitation of stroke patients. They compared their project to a “party-popper” in the way it unfurls itself when placed under a patient’s fingers, helping the stroke patient rehabilitate finger movement. Boydon shows off the testing rig built for their project. It works as a mount for their extensor, as a way to test against resistance. Their program inflates the extensor through an air pump, which then makes the extensor push against the bed whilst an arduino calculates the force created and air pressure associated with the force. Navigate Left Navigate Right
Free parking, discounts as Caesars Entertainment courts Las Vegas locals
Caesars Entertainment made a grand gesture to locals on Tuesday, extending free parking at its Las Vegas properties to all hours from Oct. 31 through Dec. 26, along with 25% off drink and dining experiences including Thanksgiving and Christmas.
Rille Pihlak: New Science, New Friendships and New Hope for Cancer Patients
Rille Pihlak: New Science, New Friendships and New Hope for Cancer Patients / cancer, ESMO, esmo 2026, ESMO Congress, ESMO26, European Society for Medical
Alternative capital finds wider acceptance
Alternative capital in the form of catastrophe bonds, sidecars and other instruments has grown significantly over the past three decades, but its use remains concentrated largely in property risks.
False lingzhi unmasked: Scientists crack the 245-year mystery behind a medicinal mushroom mix-up
In a new study published today in Plants, People, Planet, scientists from the Royal Botanic Gardens, Kew, and their international collaborators clarify the distinction between Ganoderma lucidum, a European ...
Natural Health Trends Reports Third Quarter 2026 Financial Results
Company successfully held its 25th anniversary celebration in Hong Kong in AugustActive Member count up, revenue steady with prior quarterOperating loss narrowed 57% compared to prior quarterBoard of Directors authorized additional stock repurchases, with $15.8 million available LOS ANGELES, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” produc
Better targeted actions needed to tackle unequal impacts of noise pollution for vulnerable groups
Noise pollution affects us all, but some populations like children, older adults and people with pre-existing health conditions may suffer more health wise due to excessive transport noise according to a European Environment Agency (EEA) briefing released today. The analysis recommends better targeted actions to protect vulnerable and disproportionately exposed populations.
What we learned about our politics in the 2026 Texas elections
From the governor's race to local offices, the culture wars gave way to public education and property taxes.
Two Year Lifestyle Program Improves Heart Markers Without Weight Loss
A two-year European community program shows diet and activity changes can improve cholesterol, blood sugar and waist size even without dropping pounds.
Finding biomarkers for aggressive prostate cancer
Proteins linked to the immune system, cell adhesion, blood vessel formation, and known prostate cancer genes, were associated with the future risk of developing prostate cancer, including aggressive disease, in a new study led by researchers at Oxford Population Health.
Invitation to the presentation of G5 Entertainment’s third quarter 2026
G5 Entertainment AB, a leading European casual mobile game developer and publisher will publish its financial results for the third quarter 2026 on Wednesday, November 4, 2026, at 07:00 a.m. (CET).At 08:00 a.m. (CET) on the same day, Vlad Suglobov (CEO) and Stefan Wikstrand (CFO) will host a presen…
Protecting Life Sciences Trade Secrets: From Development to the AI Era
For life sciences companies, some of their most valuable information may exist outside the protections afforded by patents and other intellectual property rights. From product development and clinical data to manufacturing processes, customer information, pricing strategies, and competitive intelligence, protecting sensitive information as a trade secret requires companies to identify what is truly valuable and take reasonable measures to maintain its secrecy.
Wilmington Health facility sells for $9.4M
Wilmington Health’s main facility recently sold for more than $9 million. The 66,000-square-foot facility located at 1202 Medical Center Drive was purchased by Charlotte-based real estate investment firm Cedar Square in a $9.4 million sale-leaseback transaction, according to a deed recorded Oct. 21. Wilmington Health will continue leasing the facility, CEO Jeff James told the Business Journal in September. James said the lease term would likely be five years, with most services eventually transferring to a new medical office building under construction in the Midtown Park office area near The Pointe at Barclay. The Wilmington Health facility was originally listed earlier this year at $11.85 million. A Wilmington Health representative did not respond to a request for comment by press time. Steve Hall, vice president of BlueCoast Commercial, represented Wilmington Health in the transaction. “Wilmington Health wanted to unlock the value in its real estate without disrupting a single patient visit, and a sale-leaseback let them do exactly that,” said Hall in a text to the Business Journal Monday. “Cedar Square gets a long-term, absolute net investment anchored by one of the region’s leading physician groups, and Wilmington Health keeps its home on Medical Center Drive while redeploying that capital into care.” The sale marks Cedar Square’s first entry into the Wilmington market, according to Jon Dixon, the firm's managing partner and founder. “We are attracted to Wilmington's growth and what we see as strong long-term fundamentals,” said Dixon in an email Monday. “Population growth, relative affordability, and quality of life make it a compelling market for us. The climate and proximity to the coast are a big part of that appeal.” He added, “We hope to pursue additional opportunities across retail, industrial, medical office and multifamily in Wilmington. We will evaluate opportunities individually and remain disciplined about the properties we pursue. We would like this acquisition to be the beginning of a broader investment presence in Wilmington.” Given the facility’s age, Dixon said the site could eventually be redeveloped, potentially for medical office space or housing. Dixon said recent announcements from UNC Health and Atrium were among the factors behind the firm’s growing interest in Wilmington’s medical-office market. The announcements involve competing proposals for hospital expansion in New Hanover County, which are subject to the state’s Certificate of Need process. “Medical office remains one of the most sought-after asset classes in commercial real estate,” said Hall, “and well-located (medical office buildings) with strong operators are scarce in Southeastern North Carolina.” According to Dixon, Cedar Square describes itself as a boutique, hands-on real estate investment firm that values direct relationships with tenants and the communities where it owns property. “We’re very hands-on, and we like to be in direct contact with all of our tenants and the communities in which we own,” Dixon said. He added, “We’re definitely interested in building a presence with local owners, brokers and businesses or tenants.”
Europe takes cancer science into immunology
Inspired by technology and insights gleaned from cancer research, Europe is leading the quest for a new generation of therapies in immunology and inflammation. Immunotherapy has revolutionised cancer therapy and become standard of care in many areas of oncology but it has also begun to change outcomes in inflammatory and autoimmune diseases.
Corning’s American Tradition of Knowledge in Materials Science
Founded in 1851 in upstate New York, where it remains, Corning is a manufacturer of specialized glass that has a market capitalization of over $100 billion as of October 2026 (GLW), annual revenues approaching $20 billion, and nearly 70,000 employees worldwide.1 Corning is the world’s leading manufacturer of touchscreen glass, one of the world’s leading manufacturers of optical fiber for long-distance telecommunication, the leading U.S. manufacturer of polysilicon for solar panels, and one of two suppliers of glass for extreme ultraviolet (EUV) photomasks needed to make the world’s most powerful chips with ASML machines. Optical fiber is also increasingly crucial to expand the computational capacity of AI data centers with optical networking. Corning is a rare jewel of the American Industrial Revolution that has not just remained competitive to the present day but repeatedly enabled technological transformations: it developed the glass for Thomas Edison’s first light bulbs in the 1880s, invented optical fiber cable in the 1970s, and developed the “Gorilla Glass” touchscreens for Apple’s iPhones that kicked off the global smartphone revolution in the 2000s. Corning’s leading tradition of knowledge in materials science has allowed it to stave off successive waves of competition over the decades from Europe, Japan, and now China.
DOMSKY: Vanderbilt’s business fraternities are playing favorites
Vanderbilt’s business fraternity recruitment process: a living hell. There are three main business fraternities at Vanderbilt: Delta Sigma Pi, Alpha Kappa Psi and Phi Chi Theta. Each one has different members, values and culture. But one thing is common to all three: a similarly competitive rush process for potential new members, or PNMs. And surprisingly,...
How Liv Cooke Built A £100 Million Property Business In Her Twenties
Freestyle football champion Liv Cooke built a £100 million property business in her twenties. Now she is investing in entrepreneurs on Property Elevator.
Pentagon investigates freezer failures as French attacks expose coverage gaps
Suspected cyber attacks at US military stores put the gap between cyber and property coverage under scrutiny
Exploring America's Political Extremes: Two Clingendael Alerts
What radical new conservative and progressive ideas in the USA could mean for EuropePolitical polarization is a
Support Hubs Help New Researchers Break Through Bottlenecks at Big Science Facilities
A formative evaluation of a Horizon Europe project finds that dedicated support hubs significantly raise the odds that new researchers clear technical feasibility checks at European research infrastructures, while a downstream gap between laboratory validation and industrial
Trump tamed after US midterms? Europe doubts it
President Donald Trump may be facing a political pounding at the US midterm elections next month -- but in Europe expectations are low that a big Democrat win would change much.While a Democrat win co...
Scientists discover a secret glow in toxic fire salamanders
Researchers have discovered a surprising hidden ability in Europe's familiar black-and-yellow fire salamanders: they glow green and cyan under ultraviolet light. The mysterious fluorescence comes mainly from glands in their skin and their toxic secretions, which can continue glowing for more than 24 hours after being released.
Vucic Concedes Electoral Defeat, Setting Stage For New Era Of Serbian Politics, Relations With West
Aleksandar Vucic, Serbia's former president and dominant political figure for more than a decade, conceded defeat to the student-led protest movement in the country's parliamentary elections, potentially ushering in a new era of politics more closely aligned with Europe and away from the Kremlin.
A golden age of science is coming
It’s almost hard to remember, but just a few years ago, a lot of very smart people thought that science was in terminal decline. Respected researchers were writing papers with titles like “Are Ideas Getting Harder to Find?”, “Papers and patents are becoming less disruptive over time”, and “Slowed canonical progress in large fields of science”. In 1996, science writer John Horgan even published a book called The End Of Science: Facing The Limits Of Knowledge In The Twilight Of The Scientific Age. The fundamental idea was that the Universe only has so many insights to discover, and that we’ve picked the low-hanging fruit. It was the idea that Joseph-Louis Lagrange expressed when he said that “we cannot find more than once a system of the world to establish.” As the big ideas and the simple ideas get mined out, we’re forced to throw ever more brains at the mysteries of nature just to keep scientific progress going at a fraction of its old pace: It looked like science was hitting a wall. Then along came AI. It’s far too early to tell how much AI will eventually speed up the growth of total factor productivity. But already we can see signs of a speedup in science. Anthropic Founder Jack Clark assembled some of the hopeful data points in a recent lecture: [ Dror Poleg@drorpoleg "If you pick different parts of science, you see the same pattern show up: Progress is accelerating, and it has started to accelerate in the last two years." Jack Clark @jackclarkSF I’m speaking at the IMF in an hour about the singularity and why I believe it has begun and the choices we'll need to make. Watch live here: https://t.co/Hj9HzcXx5h 6:08 PM · Oct 18, 2026 · 21.2K Views 2 Replies · 10 Reposts · 123 Likes ](https://x.com/drorpoleg/status/2111882070376980529) Anthropic is accelerating its investment into drug discovery, and is already announcing some impressive preliminary results: [ BioTender@Junioryu136689 BREAKING: Anthropic unveils early results from six Claude-powered drug development collaborations. • 70% shorter CAR-T signaling domain • ~35,000 antibody designs • >10× tighter antibody binding • 89% less batch-record review time Still largely preclinical. Anthropic @AnthropicAI Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own. In doing so, we’ve learned much more about how Claude can support the many stages of 9:43 PM · Oct 27, 2026 · 11.2K Views 3 Replies · 24 Reposts · 205 Likes ](https://x.com/Junioryu136689/status/2115197821150495150) Claude also appears to be enabling rapid progress toward a treatment for food allergies. OpenAI, meanwhile, announced a possible breakthrough treatment for neurodegenerative disease. Meanwhile, Google Cloud Chief Scientist Pushmeet Kohli has a list of recent scientific advances that have been enabled by its new Gemini model, including breakthroughs in nuclear fusion reactor design, rare disease research, and quantum computing: [ Pushmeet Kohli@pushmeet Gemini 4 Argon is a step change in model performance. In recent weeks, it has had a transformative impact on the Science projects in our team at @GoogleDeepMind and our external collaborators, and helped make a number of remarkable advances across scientific disciplines. 🧵👇 4:47 PM · Oct 13, 2026 · 36.5K Views 8 Replies · 41 Reposts · 497 Likes ](https://x.com/pushmeet/status/2110049807385702623) But as cool as these stories sound, they’re just very minor, preliminary efforts. There are a number of reasons to think that AI is going to propel us into a golden age of scientific discovery. That age might not last forever — AI might still run into diminishing returns eventually. But the next few decades are probably going to be an absolutely amazing time for human science. The number of “effective researchers” is no longer limited The most important input into science is scientists themselves. Until this year, that meant human brains — talented, highly trained human brains. The number of trained human brains could be increased by sending more people to grad school, but only to a point — the smartest people tend to be sent into the hardest research fields first, and if you 10x the number of researchers, the average quality will go down. This constraint was already starting to bite, as Ekerdt and Wu argued in 2024: We argue that a substantial portion of the downward historical trend in U.S. research productivity is a composition effect resulting from self-selection in researcher ability and the dramatic expansion of the research sector…[W]e find that this composition effect has lowered average researcher ability by between 37% and 53%[.] And of course, low fertility was making the problem worse, because fewer children meant fewer people who were able to become future scientists. AI just blows up this constraint completely. If an AI agent can function as an autonomous researcher, there’s no constraint on the number of researchers in the world — you can just build more of them, by building more computer chips and data centers that enable the running of more AI agents. Whether or not massive hordes of agents can collaborate to solve individual problems much faster, increasing the number of agents allows them to tackle many different research questions in parallel. What’s more, these AI “researchers” can be trained incredibly quickly compared to human beings. A human scientist takes decades to train, and more years to reach the frontier of their research field by diligent reading and conversation. This is the “burden of knowledge”, and it’s commonly believed to be one reason ideas have been getting harder to find — by the time human scientists can get up to speed, they’re often so old that their ideas are no longer novel. AI just annihilates this constraint — it can assimilate the entire literature and reach the frontier of research extremely quickly, and it can also tell human scientists where the frontier lies without forcing them to discover that for themselves. It can also pivot to new research directions more easily than humans can. And there’s also a self-reinforcing economic cycle here. Because scientific advances enable higher GDP, they enable more resources to be invested into the creation of yet more electronic “scientists”. Now that doesn’t mean the amount of scientific research goes to infinity — there may still be some essential bottleneck task that human researchers are still needed to perform. There are some indications that AI’s progress on open-ended conceptual research tasks is slower than in other dimensions, and it may be that humans are still needed to provide some of this long-term conceptual thinking. I’d bet against this being true for much longer, but it might be true for a long time. Even in this most “pessimistic” case, though, the amount of effective capital that scientists can use to leverage their work just went up by a lot. AI eliminates the theory bottleneck Science proceeds by an iterative process of theory and experiment. The theory part of that cycle is typically short, but non-trivial — it took a couple of years after the blackbody radiation spectrum was observed for Max Planck to come up with the quantum hypothesis to explain it, and decades longer before quantum theory as we now know it was created. It took about a year for Watson and Crick to figure out the shape of DNA after the requisite data was gathered. AI will basically eliminate the theory bottleneck entirely — or at least shorten the turnaround time between experiment and theory by an order of magnitude. AI is an absolute beast at math. Recently, an OpenAI model solved some of the most important open problems in computer science, math, and theoretical physics, and no one even batted an eyebrow because that sort of triumph is becoming increasingly commonplace. One of those solutions was a proof that the Standard Model of Particle Physics could be mathematically well-defined — a problem that human theorists had so far been unable to tackle. Not all research relies equally on theory, but understanding novel experimental results almost always involves some important component of either mathematical or spatial reasoning. That part of the task has now been made much, much faster. And on top of that, science is now open to a greater number of humans who aren’t naturally good at theorizing. AI can read the whole literature Much of the work of human scientists involves reading and understanding endless amounts of papers and going to endless conferences and seminars. The purpose of that work is to understand the existing scientific literature. Understanding the literature allows scientists to do the following things: Come up with new ideas for hypotheses to test Avoid doing research that someone else has already done Synthesize approaches from different areas or fields AI can reduce this effort to almost zero. Consider this excerpt from OpenAI’s blog post about their new research into neurodegenerative disease: The team divided the analysis among thousands of AI agents powered by GPT‑Rosalind, an approach we call distributed biological reasoning. The agents examined a whole-brain CRISPR atlas…a dataset showing how gene disruptions affect different types of cells across the mouse brain. Each agent investigated a gene disruption, analyzed cellular responses, searched scientific literature, and proposed explanations for the results. Their reports were combined into a reasoning atlas linking genes, cellular effects, relevant publications, and possible biological mechanisms. The research team estimated that comparable human analysis and literature review, conducted one perturbation at a time, would take months to a year. The agents reproduced findings from human analyses while uncovering additional leads. Their assessments of novelty and scientific value also aligned with judgments from blinded human experts. These findings help prioritize further experiments needed to test the proposed biological mechanisms. Some of these insights point to new leads for understanding brain disease. [emphasis mine] This is one case in which parallel work by a large number of agents really does make a huge difference: [ Haider.@haider1 this is actually insane openai deployed thousands of GPT-Rosalind agents to analyze millions of mouse brain cells in 32 minutes, work that could take human researchers months to a year also the agents uncovered new leads for brain diseases like Alzheimer's and Parkinson's OpenAI @OpenAI GPT-Rosalind surfaced a new lead for drug discovery: could restoring cholesterol transport protect neurons from degeneration? DCTN1 is a gene linked to Perry syndrome, a rare neurodegenerative disorder. In mouse-brain data, disrupting it increased expression of genes involved in 2:41 PM · Oct 21, 2026 · 51.5K Views 26 Replies · 95 Reposts · 1.26K Likes ](https://x.com/haider1/status/2112917197903540516) Not only does instantaneous literature review vastly speed up the research process, but it allows AI to make novel conceptual leaps from combining approaches from wildly different fields of research. AI regularly does this in math research, combining results, approaches, and theorems from far-flung places that no human mathematician would have thought to combine. It can do it in science, too. Much of scientific innovation, historically, has been “recombinant” innovation — scientists applying insights from one field to another. With AI, essentially all research is now cross-disciplinary — AI can read not just the literature on a particular subject, but the literature on a million other subjects that might have produced useful techniques or insights for the problem at hand. Superscience So far, all of the factors I’ve listed are ways that AI can speed up science as it’s already done. I’ve basically described how AI can send gigantic hordes of superhumanly fast, superhumanly well-read, superhumanly mathematically gifted researchers to re-accelerate scientific discovery. But it’s also possible that AI will enable types of discovery — and ways of understanding the natural world — that no network of humans, no matter how large or how brilliant it was or how long it had to work, would ever be able to discover. In a post back in July, I wrote about how that might work: What if there are lots of…aspects of the Universe that [are] too complex to understand in terms of simple laws, but not so complex that they just dissolve into unknowable chaos? It’s possible that we can reliably control these complex phenomena with AI, even if we never reduce them to the kind of principles that we can teach a grad student in a textbook… Another way of saying this is that there may be laws of the universe that humans can’t understand but AI can. I call these “cloud laws” — causal regularities that can be exploited by technology, but which are too diffuse and complex for an individual human being to either intuit or communicate… Perhaps social sciences like economics, sociology, and political science obey similarly complex regularities, and AI can help us find them. Perhaps there are physical processes — plasma, or topological materials, or aerial turbulence, etc. — that obey cloud laws instead of chaos?… [H]uman collaboration is bottlenecked — it’s limited by our ability to intuit patterns at an individual level, and to communicate these patterns from one individual to another. AI, being a computer, just doesn’t have this sort of limitation; it can work with vast, diffuse patterns without having to break them into pieces or simplify them in order to compress them into the tiny pipelines of person-to-person explanation… If much of the Universe turns out to be ruled by cloud laws, we could be on the precipice of a scientific renaissance. In order to discover cloud laws, AI will need huge amounts of data about the natural world. AI figured out human speech by assimilating essentially all of the text humans have ever written. If it’s going to figure out hidden patterns in biology, neuroscience, materials science, etc., it’s going to need similarly massive amounts of data from physical instruments. That data will be far, far more than humans — individually or collectively — would be able to parse, label, characterize, or model. But AI was built to do this. If scientists simply build huge arrays of sensors to measure complex phenomena like the brain, the cell, the economy, etc., they may be able to feed this flood of data to AI directly and bypass human cognitive intermediation entirely. AI would then learn about the world directly, and it might learn things that humans never could. This “superscience”, if you want to call it that, would actually go beyond the kind of science humans have done heretofore. Many of the technologies it yielded would be beyond human comprehension — indistinguishable from magic. But to the AIs, they would make perfect scientific sense. In any case, it seems clear that the scientific slowdown that threatened human progress will now be delayed — at least for a while. Unless humans have somehow found most of the actual exploitable regularities in our Universe, we’re about to enter a new golden age of science. Subscribe Share
FCRA finances show declining property sales, major capital spending
The Fort Chaffee Redevelopment Authority (FCRA) reported declining property-sale revenue between 2021 and 2025, while expenditures fluctuated significantly as the authority continued redevelopment and infrastructure projects at Chaffee Crossing. A...
Reckitt cuts sales outlook as Lysol and China businesses hit
Group’s European business returned to growth despite ‘challenging’ consumer environment and lower cold and flu incidence
China’s 5-year plan to accelerate science innovation is putting the U.S. and Europe in the rearview mirror
China is pouring money and political muscle into science, and the gap with the West is closing fast — by some measures, it’s already gone. As Nature’s
Protesters Storm Rome’s Colosseum as Political Unrest Surges
Demonstrators forced their way inside Rome’s Colosseum on Saturday amid political and economic unrest that has rocked Europe in recent days. NBC’s Raf Sanchez reports for TODAY.
Atari Hotels Begins Construction on Phoenix Gaming and Entertainment Development
Atari Hotels is beginning construction on its first gaming-themed hospitality and entertainment property in Phoenix’s Roosevelt Row district, with developer... Read More
Burnham open to 'honest discussion' on EU free movement
The PM said he wants a "factual" and "evidence-based debate" about returning to free movement between Britain and Europe.
Zelda 40th Anniversary Switch 2 restock: Walmart and Target confirm exact release dates
🎮 The Zelda 40th anniversary Switch 2 is out today, October 29, but Walmart and Target are planning online restocks for November 6 🚨 Our Zelda Switch 2 restock tracker @mattswider on X will send out an alert as soon as stock appears 👀 Walmart was our top pick to have a restock, but a supply chain delay has pushed the date back ⌚ GameStop, Best Buy, and Nintendo are holding in-store midnight launches where units will be available Walmart: Zelda Switch 2 console Best Buy: Zelda Switch 2 console GameStop: Zelda Switch 2 console Target: Zelda Switch 2 console Nintendo: Zelda Switch 2 console 🚨 We’re tracking Zelda Switch 2 stock updates. If you’d like to know when more stock arrives, follow Matt Swider on X and turn on notifications. You can also become a free or paid subscriber to The Shortcut to help support our work. 🚨 A new update has dashed our hopes of a major Walmart restock of the Zelda Switch 2 console, which we were confident would happen today. However, a new Reddit post (thanks, Wario64) has revealed that Walmart is waiting until at least November 6 to sell the special edition console online. 🚨 Want the Zelda 40th Anniversary Switch 2? Drop your email for restock alerts before it sells out. ⤵️ Subscribe A employee note says: “Due to a supply chain delay, some stores may not receive the Nintendo Switch 2 Zelda 40th Anniversary Edition in time for its planned Oct. 29 release. To allow time to fulfill preorders and reshop inventory as needed, the point-of-sale (POS) block will remain in place through at least Friday, Nov. 6. As inventory arrives, orders will be fulfilled based on preorder priority and available inventory.” The Redditor who posted the news shared that some people were able to get the console from Walmart after 8:00am local time, so there is still hope. Target recently updated its Zelda Switch 2 listing to reveal that it will also start taking orders of on November 6, with in stores orders beginning November 5. Clearly, the supply chain delay is impacting other stores, otherwise we likely would have seen a restock take place today, as we initially predicted. We now know that Walmart and Target will be taking online orders, and that Best Buy and Nintendo are holding in-store events on November 5. GameStop is also letting customers pre-order in-store via their website. Despite the news, we’ll still be tracking every retailer with our restock tracker, which provides up-to-the-second information whether something is in stock. If the Zelda Switch 2 does appear – which it might – our followers will still be one of the first to know. Up next: PS5 Pro restock: it’s available again, but you’re paying more than you should Subscribe Adam Vjestica is The Shortcut’s Senior Editor. Formerly TechRadar’s Gaming Hardware Editor, Adam has also worked at Nintendo of Europe as a Content Marketing Editor, where he helped launch the Nintendo Switch. He also runs a retro gaming YouTube channel called Game on, boy! Follow him on X @ItsMrProducts.
What European students can learn from their Serbian peers
The Serbian student mobilisation chose a political strategy that ensured its success where others had failed.
Couple Turns Lifelong Dream of Saving ‘Old, Dilapidated’ N.Y.C. Brownstones into a Growing Business (Exclusive)
One couple has turned their passion for restoring historic New York City guesthouses into a family business while raising three daughters and renovating every property during a pregnancy.
SAP wants Joule to run business workflows, not just answer questions
Joule Work and Joule Studio will bring together agent creation, orchestration and business context, with new interoperability and governance features designed to coordinate agents across applications and providers.